Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Php195 - Do Companies’ Market Access Training Capabilities Address the Needs of Today’s Complex Payer Marketplace?

Value in Health

English

Php359 - Impact of Expedited Marketing Authorisation on Pricing and Reimbursement Outcomes for Drugs in the Us and Eu-5

English

Prs76 - Disease Adaptation and Perceived Health Status: Does It Exist and Can It Be Quantified? Investigating Eq-5d in Severe Asthma

English

Pcv156 - Correlation of the Disease-Specific CSS/Nyha Classification With Generic Health-Related Quality of Life in Coronary Artery Disease Patients

English

Human Papilloma Virus in Italy: Cost of Illness and Potential Savings Due to HPV9 Primary Prevention

English

Pcp61 - Evidence-Based Value of Pd-1 / Pd-L1 Inhibitors in Nsclc: Comparison of Value to Price

English

Pcv149 - A Systematic Literature Review (Slr) of Health State Utilities Associated With Non-Fatal Myocardial Infarction (Mi) or Acute Coronary Syndrome (Acs)

English

Pcn75 - Budget Impact Model of Subcutaneous Trastuzumab Compared With Intravenous Trastuzumab on the Treatment of Her-2 Positive Breast Cancer in the Brazilian Private Healthcare System

English

Prs79 - Modeling the Population Years of Life Saved by Introducing a Reduced-Risk Product in the U.S. And in Japan

English

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Php195 - Do Companies’ Market Access Training Capabilities Address the Needs of Today’s Complex Payer Marketplace?

Php359 - Impact of Expedited Marketing Authorisation on Pricing and Reimbursement Outcomes for Drugs in the Us and Eu-5

Prs76 - Disease Adaptation and Perceived Health Status: Does It Exist and Can It Be Quantified? Investigating Eq-5d in Severe Asthma

Pcv156 - Correlation of the Disease-Specific CSS/Nyha Classification With Generic Health-Related Quality of Life in Coronary Artery Disease Patients

Human Papilloma Virus in Italy: Cost of Illness and Potential Savings Due to HPV9 Primary Prevention

Pcp61 - Evidence-Based Value of Pd-1 / Pd-L1 Inhibitors in Nsclc: Comparison of Value to Price

Pcv149 - A Systematic Literature Review (Slr) of Health State Utilities Associated With Non-Fatal Myocardial Infarction (Mi) or Acute Coronary Syndrome (Acs)

Pcn75 - Budget Impact Model of Subcutaneous Trastuzumab Compared With Intravenous Trastuzumab on the Treatment of Her-2 Positive Breast Cancer in the Brazilian Private Healthcare System

Prs79 - Modeling the Population Years of Life Saved by Introducing a Reduced-Risk Product in the U.S. And in Japan

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England